Login / Signup

Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma.

Houda BahigFrancine AubinJohn StaggOlguta GologanOlivier BallivyEric BissadaFelix-Phuc Nguyen-TanDenis SoulièresLouis GuertinEdith FilionApostolos ChristopoulosLouise LambertMustapha TehfeTareck AyadDanielle CharpentierRahima JamalPhilip Wong
Published in: BMC cancer (2019)
NCT03283605 . Registration date: September 14, 2017; version 1.
Keyphrases
  • early stage
  • squamous cell carcinoma
  • phase iii
  • locally advanced
  • small cell lung cancer
  • study protocol
  • phase ii
  • psychometric properties
  • clinical trial
  • radiation therapy
  • radiation induced
  • open label
  • rectal cancer